DiaMedica Therapeutics Inc. (DMAC) Depreciation USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2024.
  • DiaMedica Therapeutics Inc. Depreciation for the quarter ending March 31, 2024 was $8 K, a 14.3% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Depreciation for 2023 was $30 K, a 20% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Depreciation for 2022 was $25 K, a 4.17% increase from 2021.
  • DiaMedica Therapeutics Inc. annual Depreciation for 2021 was $24 K, a 14.3% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8 K +$1 K +14.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $7 K +$1 K +16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $6 K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $6 K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $6 K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $6 K +$2 K +50% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $4 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.